A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers
Clinical trial NCT04466891 · COMPLETED
Trial details
- NCT number
- NCT04466891
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2023-07-28
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.